Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Age-related neurodegeneration and cognitive impairments of NRMT1 knockout mice are preceded by misregulation of RB and abnormal neural stem cell development.Cell death & disease · 2021
   Article
2. Oncolytic virotherapy for urological cancers.Nature reviews. Urology · 2016
   Review
3. A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses.Gene therapy · 2009
   Article
4. Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication.Molecular and cellular biochemistry · 1999
   Article
5. Position-dependent transcriptional regulation of the murine dihydrofolate reductase promoter by the E2F transactivation domain.Molecular and cellular biology · 1997
   Article

Corrections and comments

• Erratum for
  Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter.1994

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as